Perot Systems, an active player on the acquisition front in healthcare last year, has announced an organizational restructuring plan that will eliminate 200 jobs worldwide and result in a $48 million nonrecurring charge. The company plans to
Perot Systems, an active player on the acquisition front in healthcare last year, has announced an organizational restructuring plan that will eliminate 200 jobs worldwide and result in a $48 million nonrecurring charge. The company plans to spread the charge over two quarters, allocating $37 million to fourth quarter 2000 (-20¢ per share) and $11 million in first quarter 2001 (-6¢ per share). As part of the reorganization, Perot Systems' marketing strategy will emphasize the three vertical channels that bring in two-thirds of its revenue: healthcare, financial services, and manufacturing. The company will also concentrate on three horizontal markets: business consulting, software engineering, and technology infrastructure services.
In moves that further increased its healthcare presence, Perot just completed two acquisitions. In December, Perot completed the purchase of Health Systems Design (a provider of healthcare payer services), and earlier this month the firm bought Covation (a managed-care services ASP).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.